|
ANDERS VEDIN
Born in 1942. M.D., Ph.D., Professor.
Chairman of the Board. Board member since 2001.
Member of Medivir's Remuneration Committee, R&D Committee and Nomination Committee. Advisor to the biotechnology and pharmaceutical industries. Professor of the Management of Medical Technologies at Chalmers University of Technology, Gothenburg, Sweden. Formerly held senior positions within the Astra group. Board member of IVA, the Royal Swedish Academy of Engineering Sciences. Chairman of CLC (UK), Cellartis AB and Resistentia Pharmaceuticals AB. Board member of Biacore AB (publ), Carlsson Research AB and Santosolve A/S (Norway).
Number of Medivir shares: 1,000 class B.
|
LARS-GÖRAN ANDRÉN
Born in 1943. B.Sc. (Eng.), Chemical Technology, Chalmers University of Technology, Gothenburg, Sweden.
Board member since 1998.
Member of Medivir's Remuneration Committee. 1992 - 2002 President, CEO and Executive Board member of Biacore International AB (publ). Board member of Biacore International AB (publ).
Number of Medivir shares: 750 class B.
|
|
ANNA MALM BERNSTEN
Born in 1961. M Sc Chem Eng.
Board member since April 2006. Own business within leadership and business development. Before then CEO and president in Carmeda AB. Formerly held different senior positions among others in Assa Abloy AB, Cortree AB, Medivir AB and within Pharmacia & Upjohn. Board member in DiaGenic and Fagerhult AB.
Number of Medivir shares: 0.
|
MAGNUS FALK
Born in 1942. B.Sc. (Econ.).
Board member since 2002.
Chairman of Medivir's Audit Committee. With Nordbanken/Nordea from 1986 to 2002, most recently as CEO of Nordea Bank Sweden and Chairman of Postgirot AB (the Swedish postal giro system). Board member of Ticket AB, Tennant AB and Koncentra AB.
Number of Medivir shares: 3,400 class B.
|
|
DONNA JANSON
Born in 1954. Board member since 2007. Chairman of the Medivir R&D Committee, member of the Renumeration Committee. President & CEO of Novalar Pharmaceuticals Inc. Previously President & CEO of Biora AB. Board member Axenic Dental, Inc.
Number of Medivir shares: 0
|
RON LONG
Born in 1947. Board member since 2007. BA Reading University. Member of Medivir R&D- and Audit Committee. Chairman and CEO of Procognia Ltd, Chairman of Procognia (Israel) Ltd, Senior Non Executive Director of Asterand Plc and Non Executive Director of Gyros AB. Previous experience including positions within Wellcome Foundation Plc, Amersham Pharmacia and board member of Biacore AB and Automation Partnership Plc.
Number of Medivir shares: 0
|
|
BO ÖBERG
Born in 1939. Ph.D., Professor.
Board member since 1988.
Member of Medivir's Nomination Committee. Board member of BioAgri AB, Agrivir AB, Medivir UK, Microbial Antagonism against Fungi and the Advisory Board Centre for Infectious Medicine. Chairman of the Advisory Board, RAPID Centre.
Number of Medivir shares: 284,000 class A and
333,280 class B.
|
BJÖRN C ANDERSSON
Born in 1946.Board member since April 2008.
Björn C. Andersson is currently Chairman of the Board of Euroben Life and Pension Ltd, Nordben Life and Pension Insurance Co. Ltd and Nordic Access Buyout Fund AB. Board member of D. Carnegie & Co AB and Carnegie Investment Bank AB. |
|
INGEMAR KIHLSTRÖM
Born in 1952. Board member since April 2008.
Ingemar Kihlström is Chairman of the Board of MedCap AB, KaroCell Tissue Engineering AB, Prolight Diagnostics AB and Artimplant AB. Board member of several companies.
Number of Medivir shares : 2.180 class B.
|
GÖRAN PETTERSSON
Born in 1945. Board member since April 2008.
Göran Pettersson is Chairman of the Board of OxyPharma AB, Inhalox AB, IPSAT Therapies Oy, Lund University Bioscience AB and Spectracure AB. Board member of several companies.
|
|
AUDITORS
PricewaterhouseCoopers AB was elected Auditors at the Annual General Meeting in April 2008 for the period until the AGM 2012.
Authorized Public Accountant Claes Dahlén.
|
|
